Michael Cloonan, President & CEO: Sionna Therapeutics SION Planned sale · Filed 25/08/20

Trade details

Type: Planned sale notice
Stock: Sionna Therapeutics SION
Person: Michael CloonanPresident & CEO
Planned sale date: 25/08/20
Filed: 25/08/20

$537K to be sold

Sionna Therapeutics trades, last 26 weeks

What else happened in Sionna Therapeutics around then

Filed or reported within 30 days of the trade day · 25/07/21~25/09/19

Michael Cloonan's recent trades

Michael CloonanPresident & CEO
Sell10b5-1 planSionna Therapeutics
Sell10b5-1 plan
Sionna Therapeutics
SION
$1.3M
33,532 sh
$1.3M
Filed 25/10/22
Traded 25/10/21
Michael CloonanPresident & CEO
Sell10b5-1 planSionna Therapeutics
Sell10b5-1 plan
Sionna Therapeutics
SION
$1.1M
30,049 sh
$1.1M
Filed 25/10/22
Traded 25/10/21
Michael CloonanPresident & CEO
Sell10b5-1 planSionna Therapeutics
Sell10b5-1 plan
Sionna Therapeutics
SION
$838K
22,895 sh
$838K
Filed 25/10/22
Traded 25/10/21
Michael CloonanPresident & CEO
Sell10b5-1 planSionna Therapeutics
Sell10b5-1 plan
Sionna Therapeutics
SION
$458.9K
13,324 sh
$458.9K
Filed 25/10/22
Traded 25/10/21
Michael CloonanPresident & CEO
Planned sale10b5-1 planSionna Therapeutics
Planned sale10b5-1 plan
Sionna Therapeutics
SION
$3.2M
99,800 sh
$3.2M
Filed 25/10/21
Traded 25/10/21

Michael Cloonan, CEO — plans to sell 25,000 sh of Sionna Therapeutics SION · $537K · around 08/20 · 10b5-1 plan | Whalegun